SI3096786T1 - Kapsularni polisaharidi streptococcus pneumoniae in njihovi konjugati - Google Patents

Kapsularni polisaharidi streptococcus pneumoniae in njihovi konjugati

Info

Publication number: SI3096786T1
Authority: SI; Slovenia
Prior art keywords: conjugates; streptococcus pneumoniae; capsular polysaccharides; pneumoniae capsular; polysaccharides
Prior art date: 2014-01-21

Application number

SI201531683T

Other languages

English (en)

Inventor

Mingming Han

Avvari Krishna Prasad

David Cooper

Wendy Jo Watson

Original Assignee

Pfizer Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2014-01-21

Filing date

2015-01-15

Publication date

2021-09-30

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=52630421&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI3096786(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2015-01-15 Application filed by Pfizer Inc. filed Critical Pfizer Inc.

2021-09-30 Publication of SI3096786T1 publication Critical patent/SI3096786T1/sl

Links

241000193998 Streptococcus pneumoniae Species 0.000 title 1
150000004676 glycans Chemical class 0.000 title 1
229920001282 polysaccharide Polymers 0.000 title 1
239000005017 polysaccharide Substances 0.000 title 1
229940031000 streptococcus pneumoniae Drugs 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
- A61K39/092—Streptococcus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0003—General processes for their isolation or fractionation, e.g. purification or extraction from biomass
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6031—Proteins
- A61K2039/6068—Other bacterial proteins, e.g. OMP
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Microbiology (AREA)
Epidemiology (AREA)
Immunology (AREA)
Mycology (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pulmonology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Sustainable Development (AREA)
Genetics & Genomics (AREA)
Polymers & Plastics (AREA)
General Engineering & Computer Science (AREA)
Materials Engineering (AREA)
Biotechnology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)
Medicinal Preparation (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

SI201531683T 2014-01-21 2015-01-15 Kapsularni polisaharidi streptococcus pneumoniae in njihovi konjugati SI3096786T1 (sl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US201461929561P	2014-01-21	2014-01-21
EP15708581.2A EP3096786B1 (en)	2014-01-21	2015-01-15	Streptococcus pneumoniae capsular polysaccharides and conjugates thereof
PCT/IB2015/050316 WO2015110942A2 (en)	2014-01-21	2015-01-15	Streptococcus pneumoniae capsular polysaccharides and conjugates thereof

Publications (1)

Publication Number	Publication Date
SI3096786T1 true SI3096786T1 (sl)	2021-09-30

Family

ID=52630421

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
SI201531683T SI3096786T1 (sl)	2014-01-21	2015-01-15	Kapsularni polisaharidi streptococcus pneumoniae in njihovi konjugati
SI201531977T SI3583947T1 (sl)	2014-01-21	2015-01-15	Kapsularni polisaharidi streptococcus pneumoniae in njihovi konjugati

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
SI201531977T SI3583947T1 (sl)	2014-01-21	2015-01-15	Kapsularni polisaharidi streptococcus pneumoniae in njihovi konjugati

Country Status (22)

Country	Link
US (3)	US20160324949A1 (sl)
EP (3)	EP3096786B1 (sl)
JP (3)	JP6585624B2 (sl)
KR (4)	KR102619514B1 (sl)
CN (2)	CN112336854A (sl)
AU (3)	AU2015208822B2 (sl)
BR (2)	BR112016016580B1 (sl)
CA (1)	CA2937190A1 (sl)
DK (2)	DK3583947T3 (sl)
ES (2)	ES2883571T3 (sl)
FI (1)	FI3583947T3 (sl)
FR (1)	FR22C1041I2 (sl)
HK (1)	HK1232133A1 (sl)
HR (2)	HRP20231504T1 (sl)
HU (2)	HUE055553T2 (sl)
IL (2)	IL311385A (sl)
MX (2)	MX371453B (sl)
PL (2)	PL3096786T3 (sl)
PT (2)	PT3583947T (sl)
RU (2)	RU2688831C2 (sl)
SI (2)	SI3096786T1 (sl)
WO (1)	WO2015110942A2 (sl)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP6612260B2 (ja)	2014-01-21	2019-11-27	ファイザー・インク	肺炎連鎖球菌（Ｓｔｒｅｐｔｏｃｏｃｃｕｓｐｎｅｕｍｏｎｉａｅ）莢膜多糖およびそのコンジュゲート
US11160855B2 (en) *	2014-01-21	2021-11-02	Pfizer Inc.	Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
EP3292146A1 (en)	2015-05-04	2018-03-14	Pfizer Inc	Group b streptococcus polysaccharide-protein conjugates, methods for producing conjugates, immunogenic compositions comprising conjugates, and uses thereof
PE20240927A1 (es) *	2015-07-21	2024-04-30	Pfizer	Composiciones inmunogenas que comprenden antigenos de sacarido capsular conjugados, kits que las comprenden y sus usos
IL264553B2 (en)	2016-08-05	2023-04-01	Sanofi Pasteur Inc	A multivalent pneumococcal protein-polysaccharide conjugate preparation
TWI789357B (zh)	2016-08-05	2023-01-11	南韓商Ｓｋ生物科技股份有限公司	多價肺炎球菌多醣-蛋白質共軛物組成物(二)
US11844829B2 (en)	2016-12-28	2023-12-19	Zalvac Ab	Microparticles from Streptococcus pneumoniae as vaccine antigens
CA3048981A1 (en)	2016-12-30	2018-07-05	Sutrovax, Inc.	Polypeptide-antigen conjugates with non-natural amino acids
US11951165B2 (en)	2016-12-30	2024-04-09	Vaxcyte, Inc.	Conjugated vaccine carrier proteins
ES2911490T3 (es) *	2017-01-20	2022-05-19	Pfizer	Composiciones inmunogénicas para su uso en vacunas antineumocócicas
WO2018144439A1 (en)	2017-01-31	2018-08-09	Merck Sharp & Dohme Corp.	Methods for making polysaccharide-protein conjugates
CA3052621A1 (en)	2017-02-03	2018-08-09	Schadeck, Eva Barbara	Haemophilus influenzae saccharide-carrier conjugate compositions and uses thereof
CN110337307A (zh)	2017-02-24	2019-10-15	默沙东公司	增强肺炎链球菌多糖-蛋白缀合物的免疫原性
WO2018222741A1 (en) *	2017-05-31	2018-12-06	Oklahoma Medical Research Foundation	Bispecific antibodies for the treatment of streptococcus pneumonia
US10729763B2 (en)	2017-06-10	2020-08-04	Inventprise, Llc	Mixtures of polysaccharide-protein pegylated compounds
KR102634811B1 (ko)	2017-06-10	2024-02-06	인벤트프라이즈 인크.	면역원성과 항원항체 결합성이 개선된 2가 또는 다가 접합체 다당류를 가진 다가 접합체 백신
WO2019043245A1 (en) *	2017-09-04	2019-03-07	London School Of Hygiene And Tropical Medicine	MICROBIAL CELLS EXPRESSING STREPTOCOCCAL SERROTYPES
CA3074703A1 (en)	2017-09-07	2019-03-14	Merck Sharp & Dohme Corp.	Pneumococcal polysaccharides and their use in immunogenic polysaccharide-carrier protein conjugates
JP7218358B2 (ja)	2017-09-07	2023-02-06	メルク・シャープ・アンド・ドーム・エルエルシー	肺炎球菌多糖体および免疫原性多糖体－キャリアタンパク質コンジュゲートでのその使用
JP7369123B2 (ja) *	2017-12-06	2023-10-25	メルク・シャープ・アンド・ドーム・エルエルシー	肺炎球菌多糖類－タンパク質コンジュゲートを含む組成物およびその使用方法
US11123417B2 (en)	2018-02-05	2021-09-21	Sanofi Pasteur Inc.	Multivalent pneumococcal polysaccharide-protein conjugate composition
CA3087572A1 (en)	2018-02-05	2019-08-08	Sanofi Pasteur Inc.	Multivalent pneumococcal polysaccharide-protein conjugate composition
AU2019256218A1 (en)	2018-04-18	2020-12-03	Sk Bioscience Co., Ltd.	Streptococcus pneumoniae capsular polysaccharides and immunogenic conjugate thereof
KR20210005158A (ko) *	2018-04-30	2021-01-13	머크 샤프 앤드 돔 코포레이션	스트렙토코쿠스 뉴모니아에 피막 폴리사카라이드 담체 단백질 접합체를 제조하는 방법
KR20210002641A (ko)	2018-04-30	2021-01-08	머크 샤프 앤드 돔 코포레이션	디메틸술폭시드 중의 동결건조된 돌연변이체 디프테리아 독소의 균질 용액을 제공하는 방법
CN112543649A (zh) *	2018-07-04	2021-03-23	Vaxcyte公司	免疫原性缀合物的改进
AU2019341723B2 (en) *	2018-09-23	2024-03-21	Biological E Limited	Purified capsular polysaccharides of Streptococcus pneumoniae
MA54533A (fr) *	2018-12-19	2022-03-30	Merck Sharp & Dohme	Compositions comprenant des conjugués polysaccharide-protéine de streptococcus pneumoniae et leurs méthodes d'utilisation
JP7239509B6 (ja) *	2019-02-22	2023-03-28	ファイザー・インク	細菌多糖類を精製するための方法
TW202116352A (zh) *	2019-07-18	2021-05-01	南韓商賽特瑞恩股份有限公司	包含多價肺炎球菌多醣-蛋白共軛物的免疫組成物、醫藥組成物及其用途
AU2020323498A1 (en) *	2019-07-31	2022-03-03	Sk Bioscience Co., Ltd.	Multivalent pneumococcal polysaccharide-protein conjugate compositions and methods of using the same
WO2021229604A1 (en) *	2020-05-14	2021-11-18	Serum Institute Of India Private Limited	Methods for simultaneous fragmentation and purification of bacterial polysaccharides
AU2021373358A1 (en) *	2020-11-04	2023-06-01	Pfizer Inc.	Immunogenic compositions for use in pneumococcal vaccines

Family Cites Families (73)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4686102A (en) *	1984-04-12	1987-08-11	American Cyanamid Company	Multivalent pneumococcal vaccine and preparation thereof
US4709017A (en)	1985-06-07	1987-11-24	President And Fellows Of Harvard College	Modified toxic vaccines
US4950740A (en)	1987-03-17	1990-08-21	Cetus Corporation	Recombinant diphtheria vaccines
US5057540A (en)	1987-05-29	1991-10-15	Cambridge Biotech Corporation	Saponin adjuvant
US4912094B1 (en)	1988-06-29	1994-02-15	Ribi Immunochem Research Inc.	Modified lipopolysaccharides and process of preparation
DE3841091A1 (de)	1988-12-07	1990-06-13	Behringwerke Ag	Synthetische antigene, verfahren zu ihrer herstellung und ihre verwendung
DE68907045T2 (de)	1989-01-17	1993-12-02	Eniricerche Spa	Synthetische Peptide und deren Verwendung als allgemeine Träger für die Herstellung von immunogenischen Konjugaten, die für die Entwicklung von synthetischen Impfstoffen geeignet sind.
JPH0832638B2 (ja)	1989-05-25	1996-03-29	カイロンコーポレイション	サブミクロン油滴乳剤を含んで成るアジュバント製剤
CA2063271A1 (en)	1989-07-14	1991-01-15	Subramonia Pillai	Cytokine and hormone carriers for conjugate vaccines
IT1237764B (it)	1989-11-10	1993-06-17	Eniricerche Spa	Peptidi sintetici utili come carriers universali per la preparazione di coniugati immunogenici e loro impiego per lo sviluppo di vaccini sintetici.
SE466259B (sv)	1990-05-31	1992-01-20	Arne Forsgren	Protein d - ett igd-bindande protein fraan haemophilus influenzae, samt anvaendning av detta foer analys, vacciner och uppreningsaendamaal
DE69113564T2 (de)	1990-08-13	1996-05-30	American Cyanamid Co	Faser-Hemagglutinin von Bordetella pertussis als Träger für konjugierten Impfstoff.
US5153312A (en) *	1990-09-28	1992-10-06	American Cyanamid Company	Oligosaccharide conjugate vaccines
CA2059692C (en) *	1991-01-28	2004-11-16	Peter J. Kniskern	Pneumoccoccal polysaccharide conjugate vaccine
CA2059693C (en) *	1991-01-28	2003-08-19	Peter J. Kniskern	Polysaccharide antigens from streptococcus pneumoniae
IL101715A (en)	1991-05-02	2005-06-19	Amgen Inc	Recombinant dna-derived cholera toxin subunit analogs
JPH07507854A (ja)	1991-12-23	1995-08-31	ツォッヒェ，ミヒャエル	油除去装置を備えたエンジン
ES2204900T3 (es)	1992-02-11	2004-05-01	Henry M. Jackson Foundation For The Advancement Of Military Medicine	Estructura inmuinogena de doble vector.
IT1262896B (it)	1992-03-06	1996-07-22		Composti coniugati formati da proteine heat shock (hsp) e oligo-poli- saccaridi, loro uso per la produzione di vaccini.
DE69324487T2 (de)	1992-05-06	1999-08-12	Harvard College	Rezeptorbindende region des diphtherietoxius
IL102687A (en)	1992-07-30	1997-06-10	Yeda Res & Dev	Conjugates of poorly immunogenic antigens and synthetic pepide carriers and vaccines comprising them
ES2231770T3 (es)	1993-03-05	2005-05-16	Wyeth Holdings Corporation	Nuevos plasmidos para la produccion de proteina crm y toxina difterica.
ATE254475T1 (de)	1993-09-22	2003-12-15	Jackson H M Found Military Med	Verfahren zur aktivierung von löslichem kohlenhydraten durch verwendung von neuen cyanylierungsreagenzien, zur herstellung von immunogenischen konstrukten
US5917017A (en)	1994-06-08	1999-06-29	President And Fellows Of Harvard College	Diphtheria toxin vaccines bearing a mutated R domain
US6455673B1 (en)	1994-06-08	2002-09-24	President And Fellows Of Harvard College	Multi-mutant diphtheria toxin vaccines
US6207646B1 (en)	1994-07-15	2001-03-27	University Of Iowa Research Foundation	Immunostimulatory nucleic acid molecules
US6239116B1 (en)	1994-07-15	2001-05-29	University Of Iowa Research Foundation	Immunostimulatory nucleic acid molecules
EP1167379A3 (en)	1994-07-15	2004-09-08	University Of Iowa Research Foundation	Immunomodulatory oligonucleotides
CA2215933C (en)	1995-03-22	2009-10-13	Andrew Lees	Producing immunogenic constructs using soluble carbohydrates activated via organic cyanylating reagents
US5714354A (en) *	1995-06-06	1998-02-03	American Home Products Corporation	Alcohol-free pneumococcal polysaccharide purification process
AU738513B2 (en)	1997-02-28	2001-09-20	University Of Iowa Research Foundation, The	Use of nucleic acids containing unmethylated CpG dinucleotide in the treatment of LPS-associated disorders
US6299881B1 (en)	1997-03-24	2001-10-09	Henry M. Jackson Foundation For The Advancement Of Military Medicine	Uronium salts for activating hydroxyls, carboxyls, and polysaccharides, and conjugate vaccines, immunogens, and other useful immunological reagents produced using uronium salts
US6113918A (en)	1997-05-08	2000-09-05	Ribi Immunochem Research, Inc.	Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors
US6339068B1 (en)	1997-05-20	2002-01-15	University Of Iowa Research Foundation	Vectors and methods for immunization or therapeutic protocols
GB9713156D0 (en)	1997-06-20	1997-08-27	Microbiological Res Authority	Vaccines
ATE356630T1 (de)	1998-04-03	2007-04-15	Univ Iowa Res Found	Verfahren und produkte zur stimulierung des immunsystems mittels immunotherapeutischer oligonukleotide und zytokine
BR9914160A (pt)	1998-09-30	2001-06-26	American Cyanamid Co	Composição antigênica, método para aumentar a capacidade de uma composição antigênica que contenha um antìgeno selecionado de uma bactéria, vìrus, fungo ou parasita patogênicos, do haemophilus influenzae, do helicobacter pylori, do vìrus sincicial respiratório, do rotavìrus, e, do vìrus simples do herpes para evocar a resposta imune de um hospedeiro vertebrado, plasmìdeo, célula hospedeira, método para produzir uma holotoxina do cólera mutante imunogênica, e, uso de uma quantidade auxiliar eficaz de uma holotoxina do cólera mutante
EP2050464B1 (en)	1998-12-21	2019-08-07	Medimmune, Inc.	Streptococcus pneumoniae proteins and immunogenic fragments for vaccines
PT2261358E (pt)	1998-12-23	2014-07-30	Id Biomedical Corp Quebec	Antigénios de streptococcus
US6936258B1 (en)	1999-03-19	2005-08-30	Nabi Biopharmaceuticals	Staphylococcus antigen and vaccine
CA2365914A1 (en)	1999-04-09	2000-10-19	Techlab, Inc.	Recombinant clostridium toxin a protein carrier for polysaccharide conjugate vaccines
GB0007432D0 (en)	2000-03-27	2000-05-17	Microbiological Res Authority	Proteins for use as carriers in conjugate vaccines
TR200704553T2 (tr)	2000-06-20	2007-11-21	Id Biomedical Corporation	Streptokok antijenleri.
AU2002309706A1 (en)	2001-05-11	2002-11-25	Aventis Pasteur, Inc.	Novel meningitis conjugate vaccine
CN1541111A (zh)	2001-06-07	2004-10-27	��Ͽع��޹�˾	作为佐剂的霍乱全毒素的突变形式
EP1404368B1 (en)	2001-06-07	2009-12-09	Wyeth Holdings Corporation	Mutant forms of cholera holotoxin as an adjuvant
US20030091593A1 (en)	2001-09-14	2003-05-15	Cytos Biotechnology Ag	In vivo activation of antigen presenting cells for enhancement of immune responses induced by virus like particles
EP1456231A2 (en)	2001-12-20	2004-09-15	Shire Biochem Inc.	Streptococcus antigens
PT1601689E (pt)	2003-03-13	2008-01-04	Glaxosmithkline Biolog Sa	Processo de purificação para citolisina bacteriana
GB0323103D0 (en)	2003-10-02	2003-11-05	Chiron Srl	De-acetylated saccharides
EP2484374A1 (en)	2004-07-18	2012-08-08	CSL Limited	Immuno stimulating complex and oligonucleotide formulations for inducing enhanced interferon-gamma responses
CN102716480B (zh)	2005-04-08	2023-03-21	惠氏有限责任公司	多价肺炎球菌多糖-蛋白质缀合物组合物
US7955605B2 (en) *	2005-04-08	2011-06-07	Wyeth Llc	Multivalent pneumococcal polysaccharide-protein conjugate composition
US7709001B2 (en)	2005-04-08	2010-05-04	Wyeth Llc	Multivalent pneumococcal polysaccharide-protein conjugate composition
NZ562719A (en)	2005-04-08	2008-12-24	Wyeth Corp	Separation of contaminants from streptococcus pneumoniae polysaccharide by pH manipulation
US20070184072A1 (en)	2005-04-08	2007-08-09	Wyeth	Multivalent pneumococcal polysaccharide-protein conjugate composition
CN101378778B (zh) *	2005-12-22	2013-02-06	葛兰素史密丝克莱恩生物有限公司	肺炎球菌多糖缀合物疫苗
RU2460539C2 (ru)	2006-10-10	2012-09-10	Вайет	СПОСОБ ОЧИСТКИ ПОЛИСАХАРИДОВ Streptococcus pneumoniae 3 ТИПА (ВАРИАНТЫ)
PL2129693T3 (pl)	2007-03-23	2017-07-31	Wyeth Llc	Skrócony sposób oczyszczania do wytwarzania polisacharydów otoczkowych Streptococcus pneumoniae
EP2170391B1 (en) *	2007-06-20	2017-01-18	Pfizer Ireland Pharmaceuticals	Modified polysaccharides for conjugate vaccines
AU2008267208B2 (en)	2007-06-26	2012-01-19	Glaxosmithkline Biologicals S.A.	Vaccine comprising streptococcus pneumoniae capsular polysaccharide conjugates
BRPI1014494A2 (pt)	2009-04-30	2016-08-02	Coley Pharm Group Inc	vacina pneumocócica e usos da mesma
US9125951B2 (en) *	2009-06-22	2015-09-08	Wyeth Llc	Compositions and methods for preparing Staphylococcus aureus serotype 5 and 8 capsular polysaccharide conjugate immunogenic compositions
TW201136603A (en)	2010-02-09	2011-11-01	Merck Sharp & Amp Dohme Corp	15-valent pneumococcal polysaccharide-protein conjugate vaccine composition
GB201003922D0 (en) *	2010-03-09	2010-04-21	Glaxosmithkline Biolog Sa	Conjugation process
RU2013131795A (ru) *	2010-12-10	2015-01-20	Мерк Шарп Энд Домэ Корп.	Новые композиции, которые уменьшают вызываемую встряхиванием агрегацию иммуногенных композиций
GB201103836D0 (en) *	2011-03-07	2011-04-20	Glaxosmithkline Biolog Sa	Conjugation process
AU2012255878B2 (en) *	2011-05-18	2016-05-12	Matrivax Research & Development Corporation	Protein matrix vaccine compositions including polycations
KR102057217B1 (ko) *	2012-06-20	2020-01-22	에스케이바이오사이언스 주식회사	다가 폐렴구균 다당류-단백질 접합체 조성물
MX363511B (es) *	2012-08-16	2019-03-26	Pfizer	Proceso de glucoconjugación y composiciones.
HRP20221438T1 (hr) *	2012-12-20	2023-02-03	Pfizer Inc.	Postupak glikokonjugiranja
EP3616716A3 (en) *	2014-01-21	2020-05-06	Pfizer Inc	Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
PE20240927A1 (es) *	2015-07-21	2024-04-30	Pfizer	Composiciones inmunogenas que comprenden antigenos de sacarido capsular conjugados, kits que las comprenden y sus usos

2015
- 2015-01-15 SI SI201531683T patent/SI3096786T1/sl unknown
- 2015-01-15 PT PT191795772T patent/PT3583947T/pt unknown
- 2015-01-15 FI FIEP19179577.2T patent/FI3583947T3/fi active
- 2015-01-15 CN CN202011016155.6A patent/CN112336854A/zh active Pending
- 2015-01-15 IL IL311385A patent/IL311385A/en unknown
- 2015-01-15 JP JP2016564448A patent/JP6585624B2/ja active Active
- 2015-01-15 HR HRP20231504TT patent/HRP20231504T1/hr unknown
- 2015-01-15 AU AU2015208822A patent/AU2015208822B2/en active Active
- 2015-01-15 ES ES15708581T patent/ES2883571T3/es active Active
- 2015-01-15 WO PCT/IB2015/050316 patent/WO2015110942A2/en active Application Filing
- 2015-01-15 BR BR112016016580-2A patent/BR112016016580B1/pt active IP Right Grant
- 2015-01-15 RU RU2016127123A patent/RU2688831C2/ru active
- 2015-01-15 MX MX2016009469A patent/MX371453B/es active IP Right Grant
- 2015-01-15 DK DK19179577.2T patent/DK3583947T3/da active
- 2015-01-15 HU HUE15708581A patent/HUE055553T2/hu unknown
- 2015-01-15 KR KR1020227039818A patent/KR102619514B1/ko active IP Right Grant
- 2015-01-15 EP EP15708581.2A patent/EP3096786B1/en active Active
- 2015-01-15 IL IL246738A patent/IL246738B1/en unknown
- 2015-01-15 SI SI201531977T patent/SI3583947T1/sl unknown
- 2015-01-15 ES ES19179577T patent/ES2965616T3/es active Active
- 2015-01-15 PL PL15708581T patent/PL3096786T3/pl unknown
- 2015-01-15 KR KR1020197034425A patent/KR102229568B1/ko active IP Right Grant
- 2015-01-15 EP EP23195316.7A patent/EP4286000A3/en active Pending
- 2015-01-15 PL PL19179577.2T patent/PL3583947T3/pl unknown
- 2015-01-15 PT PT157085812T patent/PT3096786T/pt unknown
- 2015-01-15 CN CN201580005248.XA patent/CN106413747A/zh active Pending
- 2015-01-15 US US15/110,902 patent/US20160324949A1/en not_active Abandoned
- 2015-01-15 MX MX2020001138A patent/MX2020001138A/es unknown
- 2015-01-15 EP EP19179577.2A patent/EP3583947B1/en active Active
- 2015-01-15 RU RU2019114121A patent/RU2743793C1/ru active
- 2015-01-15 DK DK15708581.2T patent/DK3096786T3/da active
- 2015-01-15 KR KR1020217007584A patent/KR20210032013A/ko active Application Filing
- 2015-01-15 BR BR122023022294-6A patent/BR122023022294A2/pt unknown
- 2015-01-15 KR KR1020167022420A patent/KR102049825B1/ko active IP Right Grant
- 2015-01-15 CA CA2937190A patent/CA2937190A1/en active Pending
- 2015-01-15 HU HUE19179577A patent/HUE064837T2/hu unknown
2017
- 2017-06-09 HK HK17105722.5A patent/HK1232133A1/zh unknown
2018
- 2018-10-22 US US16/166,708 patent/US20190070283A1/en not_active Abandoned
2019
- 2019-06-25 JP JP2019117289A patent/JP2019172701A/ja active Pending
2020
- 2020-07-06 AU AU2020204508A patent/AU2020204508B2/en active Active
- 2020-12-17 US US17/125,555 patent/US20210121555A1/en active Pending
2021
- 2021-04-05 JP JP2021063880A patent/JP7216137B2/ja active Active
- 2021-08-11 HR HRP20211288TT patent/HRP20211288T1/hr unknown
2022
- 2022-07-28 FR FR22C1041C patent/FR22C1041I2/fr active Active
2023
- 2023-03-14 AU AU2023201579A patent/AU2023201579A1/en active Pending

Also Published As

Publication number	Publication date
AU2020204508A1 (en)	2020-07-23
WO2015110942A3 (en)	2015-11-26
US20210121555A1 (en)	2021-04-29
BR112016016580A2 (pt)	2017-10-03
HRP20211288T1 (hr)	2021-11-26
AU2020204508B2 (en)	2023-02-02
SI3583947T1 (sl)	2024-01-31
RU2743793C1 (ru)	2021-02-26
CN106413747A (zh)	2017-02-15
KR102619514B1 (ko)	2023-12-28
IL311385A (en)	2024-05-01
FI3583947T3 (fi)	2023-10-12
JP2017504661A (ja)	2017-02-09
CA2937190A1 (en)	2015-07-30
JP2019172701A (ja)	2019-10-10
EP3583947A1 (en)	2019-12-25
EP4286000A2 (en)	2023-12-06
RU2016127123A3 (sl)	2018-02-28
IL246738B1 (en)	2024-04-01
EP3096786B1 (en)	2021-07-07
HRP20231504T1 (hr)	2024-03-01
AU2015208822B2 (en)	2020-06-18
MX371453B (es)	2020-01-29
JP6585624B2 (ja)	2019-10-02
RU2688831C2 (ru)	2019-05-22
PT3096786T (pt)	2021-08-24
EP4286000A3 (en)	2024-02-14
ES2965616T3 (es)	2024-04-16
PL3096786T3 (pl)	2021-11-08
IL246738A0 (en)	2016-08-31
US20160324949A1 (en)	2016-11-10
KR20160104076A (ko)	2016-09-02
ES2883571T3 (es)	2021-12-09
EP3583947B1 (en)	2023-10-11
MX2016009469A (es)	2016-10-13
JP7216137B2 (ja)	2023-01-31
HUE064837T2 (hu)	2024-05-28
KR102229568B1 (ko)	2021-03-18
CN112336854A (zh)	2021-02-09
HUE055553T2 (hu)	2021-12-28
PT3583947T (pt)	2023-12-14
EP3096786A2 (en)	2016-11-30
BR122023022294A2 (pt)	2023-12-12
AU2015208822A1 (en)	2016-07-21
KR20210032013A (ko)	2021-03-23
RU2016127123A (ru)	2018-02-28
MX2020001138A (es)	2021-09-30
BR112016016580B1 (pt)	2024-01-09
US20190070283A1 (en)	2019-03-07
PL3583947T3 (pl)	2024-04-02
AU2023201579A1 (en)	2023-04-13
FR22C1041I2 (fr)	2023-05-26
KR102049825B1 (ko)	2019-12-03
WO2015110942A2 (en)	2015-07-30
JP2021105036A (ja)	2021-07-26
FR22C1041I1 (fr)	2022-09-09
DK3583947T3 (da)	2023-11-06
HK1232133A1 (zh)	2018-01-05
DK3096786T3 (da)	2021-08-02
KR20190133066A (ko)	2019-11-29
KR20220156982A (ko)	2022-11-28

Publication	Publication Date	Title
IL283554A (en)	2021-07-29	Capsular polysaccharides of Streptococcus pneumoniae and their conjugates
HK1232133A1 (zh)	2018-01-05	肺炎鏈球菌莢膜多糖及其綴合物
IL258248A (en)	2018-05-31	Attraction Oligonucleotide Conjugates and Their Uses
IL290457A (en)	2022-04-01	Antibodies and their conjugates
IL248961A0 (en)	2017-01-31	Oristatin histories and their conjugations
FI3380124T3 (fi)	2024-05-28	Itsekatkeavia ryhmiä käsittäviä konjugaatteja ja niihin liittyviä menetelmiä
FI3110441T3 (fi)	2024-05-06	Uusi polysakkaridi ja sen käyttöjä
ZA201701337B (en)	2018-05-30	Conjugates and conjugating reagents
IL265471A (en)	2019-05-30	Pulling-oligonucleotide conjugates and their uses
IL258759A (en)	2018-06-28	Anti-cd3-folate conjugates and their uses
ZA201608327B (en)	2022-08-31	Curcumin-peptide conjugates and formulations thereof
PT3544637T (pt)	2021-02-03	Conjugados omv-antigénio nativos e sua utilização
GB201818562D0 (en)	2018-12-26	Pyrrolobenzodiazephones and conjugates thereof
GB201418986D0 (en)	2014-12-10	Novel conjugates and novel conjugating reagents